Literature DB >> 11849558

What is the basis of transmissible spongiform encephalopathy induced neurodegeneration and can it be repaired?

J R Fraser1.   

Abstract

Once an animal becomes infected with a prion disease, or transmissible spongiform encephalopathy (TSE), the progression of infection is relentless and inevitably fatal, although often with such prolonged incubation periods that an alternative cause of death can intervene. Infection has been compared to 'setting a clock' which then runs inexorably as the disease spreads, usually through the lymphoreticular system and then via peripheral nerves to the central nervous system (CNS), although the mechanism controlling the protracted progression is not known. Clinical disease develops as characteristic degenerative changes in the CNS progress, but the molecular basis for this pathology is not clear, particularly the relationship between the deposition of abnormal PrP and neuronal dysfunction. Recent research has identified several means of slowing (if not stopping) the clock when infection has not yet reached the CNS; although the potential for later stage therapies seems limited, neuroprotective strategies which have been shown to be effective in other neurodegenerative conditions may also ameliorate TSE induced CNS pathology. This review focuses on our current knowledge of the key events following infection of the CNS and the opportunities for intervention once the CNS has become infected.

Entities:  

Mesh:

Year:  2002        PMID: 11849558     DOI: 10.1046/j.1365-2990.2002.00376.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  8 in total

Review 1.  The intricate mechanisms of neurodegeneration in prion diseases.

Authors:  Claudio Soto; Nikunj Satani
Journal:  Trends Mol Med       Date:  2011-01       Impact factor: 11.951

2.  In vivo detection of prion amyloid plaques using [(11)C]BF-227 PET.

Authors:  Nobuyuki Okamura; Yusei Shiga; Shozo Furumoto; Manabu Tashiro; Yoshio Tsuboi; Katsutoshi Furukawa; Kazuhiko Yanai; Ren Iwata; Hiroyuki Arai; Yukitsuka Kudo; Yasuhito Itoyama; Katsumi Doh-ura
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-12-17       Impact factor: 9.236

Review 3.  Mahogunin Ring Finger-1 (MGRN1), a Multifaceted Ubiquitin Ligase: Recent Unraveling of Neurobiological Mechanisms.

Authors:  Arun Upadhyay; Ayeman Amanullah; Deepak Chhangani; Ribhav Mishra; Amit Prasad; Amit Mishra
Journal:  Mol Neurobiol       Date:  2015-08-09       Impact factor: 5.590

4.  New insights into early sequential PrPsc accumulation in scrapie infected mouse brain evidenced by the use of streptomycin sulfate.

Authors:  Anna A Bencsik; Edwige Leclere; Hervé Perron; Aly Moussa
Journal:  Histochem Cell Biol       Date:  2008-01-26       Impact factor: 4.304

Review 5.  Prion diseases: from protein to cell pathology.

Authors:  Gabor G Kovacs; Herbert Budka
Journal:  Am J Pathol       Date:  2008-02-02       Impact factor: 4.307

Review 6.  The Role of the Mammalian Prion Protein in the Control of Sleep.

Authors:  Amber Roguski; Andrew C Gill
Journal:  Pathogens       Date:  2017-11-17

Review 7.  Molecular pathology of human prion diseases.

Authors:  Gabor G Kovacs; Herbert Budka
Journal:  Int J Mol Sci       Date:  2009-03-09       Impact factor: 5.923

8.  Characterisation of radioiodinated flavonoid derivatives for SPECT imaging of cerebral prion deposits.

Authors:  Takeshi Fuchigami; Yuki Yamashita; Masao Kawasaki; Ayaka Ogawa; Mamoru Haratake; Ryuichiro Atarashi; Kazunori Sano; Takehiro Nakagaki; Kaori Ubagai; Masahiro Ono; Sakura Yoshida; Noriyuki Nishida; Morio Nakayama
Journal:  Sci Rep       Date:  2015-12-16       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.